SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-001522
Filing Date
2024-02-14
Accepted
2024-02-14 16:36:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 greatpoint-avtx123123a1.htm SC 13G/A 116846
  Complete submission text file 0001172661-24-001522.txt   118505
Mailing Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830 203 971-3300
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Subject) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89290 | Film No.: 24639359
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)